| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | guanylate cyclase activity | 4.07e-05 | 10 | 142 | 3 | GO:0004383 | |
| GeneOntologyMolecularFunction | natriuretic peptide receptor activity | 1.50e-04 | 3 | 142 | 2 | GO:0016941 | |
| GeneOntologyMolecularFunction | type I interferon receptor binding | 2.23e-04 | 17 | 142 | 3 | GO:0005132 | |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 2.66e-04 | 18 | 142 | 3 | GO:0004016 | |
| GeneOntologyMolecularFunction | small GTPase binding | 4.94e-04 | 321 | 142 | 9 | GO:0031267 | |
| GeneOntologyMolecularFunction | Hsp90 protein binding | 6.31e-04 | 55 | 142 | 4 | GO:0051879 | |
| GeneOntologyMolecularFunction | cyclase activity | 6.39e-04 | 24 | 142 | 3 | GO:0009975 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 7.22e-04 | 25 | 142 | 3 | GO:0016849 | |
| GeneOntologyBiologicalProcess | cellular response to type I interferon | 2.54e-05 | 86 | 139 | 6 | GO:0071357 | |
| GeneOntologyBiologicalProcess | motile cilium assembly | 2.89e-05 | 88 | 139 | 6 | GO:0044458 | |
| GeneOntologyBiologicalProcess | response to exogenous dsRNA | 3.43e-05 | 55 | 139 | 5 | GO:0043330 | |
| GeneOntologyBiologicalProcess | response to type I interferon | 3.73e-05 | 92 | 139 | 6 | GO:0034340 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | KNTC1 RGPD2 GDAP1 OBSCN TOPBP1 PTPN23 NBEA TSC2 SIN3A CUBN MTERF4 ECT2 CCDC39 GHSR TBC1D32 VPS13D INTS13 VPS13A NUP188 HTT | 4.35e-05 | 1091 | 139 | 20 | GO:0033365 |
| GeneOntologyBiologicalProcess | cGMP biosynthetic process | 6.30e-05 | 12 | 139 | 3 | GO:0006182 | |
| GeneOntologyBiologicalProcess | response to dsRNA | 6.64e-05 | 63 | 139 | 5 | GO:0043331 | |
| GeneOntologyBiologicalProcess | cilium organization | SPEF2 RTTN PTPN23 CFAP43 CCDC39 TBC1D32 TRIM32 DYNLL1 TBC1D21 BBS12 HTT CFAP46 | 9.37e-05 | 476 | 139 | 12 | GO:0044782 |
| GeneOntologyBiologicalProcess | axoneme assembly | 9.63e-05 | 109 | 139 | 6 | GO:0035082 | |
| GeneOntologyBiologicalProcess | defense response to virus | RELA SIN3A ITGAX IFIT1 IFNA4 IFNA7 IFNA10 IFIH1 TRIM32 IFIT1B | 1.11e-04 | 342 | 139 | 10 | GO:0051607 |
| GeneOntologyBiologicalProcess | response to virus | RELA SIN3A ITGAX WDFY4 IFIT1 IFNA4 IFNA7 IFNA10 IFIH1 TRIM32 IFIT1B | 1.47e-04 | 425 | 139 | 11 | GO:0009615 |
| GeneOntologyCellularComponent | striated muscle myosin thick filament | 2.88e-04 | 4 | 146 | 2 | GO:0005863 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | UNC13B APPBP2 LZTR1 COPA COPB1 GRIN1 CUBN ASB15 ITGAX SNX19 SEMA4C MCTP1 PTPRJ EGFR VPS13A AP1G2 DYNLL1 ATP6V0D2 DMD HTT DOP1B | 2.98e-04 | 1307 | 146 | 21 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | UNC13B APPBP2 LZTR1 COPA COPB1 GRIN1 CUBN ASB15 ITGAX SNX19 SEMA4C MCTP1 PTPRJ EGFR VPS13A AP1G2 DYNLL1 ATP6V0D2 DMD HTT DOP1B | 3.58e-04 | 1325 | 146 | 21 | GO:0012506 |
| Domain | ARM-type_fold | COPB1 DOCK8 RTTN ARFGEF1 NBEA TSC2 WDFY4 VIRMA NCAPG2 FMNL3 ANKAR IFRD2 LTN1 INTS4 AP1G2 ZER1 NUP188 ARMH3 HTT | 1.76e-11 | 339 | 145 | 19 | IPR016024 |
| Domain | ARM-like | COPB1 DOCK8 RTTN ARFGEF1 NBEA TSC2 WDFY4 NCAPG2 ANKAR IFRD2 LTN1 INTS4 AP1G2 ZER1 HTT | 3.03e-09 | 270 | 145 | 15 | IPR011989 |
| Domain | - | COPB1 RTTN ARFGEF1 TSC2 WDFY4 NCAPG2 ANKAR IFRD2 INTS4 AP1G2 ZER1 HTT | 1.66e-07 | 222 | 145 | 12 | 1.25.10.10 |
| Domain | TPR_REGION | 4.47e-05 | 165 | 145 | 8 | PS50293 | |
| Domain | TPR | 4.47e-05 | 165 | 145 | 8 | PS50005 | |
| Domain | HDAC_interact | 5.99e-05 | 2 | 145 | 2 | SM00761 | |
| Domain | Sin3_C | 5.99e-05 | 2 | 145 | 2 | IPR031693 | |
| Domain | Sin3_corepress | 5.99e-05 | 2 | 145 | 2 | PF08295 | |
| Domain | Sin3a_C | 5.99e-05 | 2 | 145 | 2 | PF16879 | |
| Domain | HDAC_interact_dom | 5.99e-05 | 2 | 145 | 2 | IPR013194 | |
| Domain | TPR-contain_dom | 1.72e-04 | 150 | 145 | 7 | IPR013026 | |
| Domain | PAH | 1.79e-04 | 3 | 145 | 2 | IPR003822 | |
| Domain | - | 1.79e-04 | 3 | 145 | 2 | 1.20.1160.11 | |
| Domain | PAH | 1.79e-04 | 3 | 145 | 2 | PS51477 | |
| Domain | VPS13 | 1.79e-04 | 3 | 145 | 2 | IPR026847 | |
| Domain | ANF_RECEPTORS | 1.79e-04 | 3 | 145 | 2 | PS00458 | |
| Domain | VPS13_mid_rpt | 1.79e-04 | 3 | 145 | 2 | PF16910 | |
| Domain | VPS13 | 1.79e-04 | 3 | 145 | 2 | PF16908 | |
| Domain | VPS13_N2 | 1.79e-04 | 3 | 145 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 1.79e-04 | 3 | 145 | 2 | IPR031642 | |
| Domain | PAH | 1.79e-04 | 3 | 145 | 2 | PF02671 | |
| Domain | ANPR/GUC | 1.79e-04 | 3 | 145 | 2 | IPR001170 | |
| Domain | A/G_cyclase_CS | 2.88e-04 | 17 | 145 | 3 | IPR018297 | |
| Domain | Interferon | 2.88e-04 | 17 | 145 | 3 | PF00143 | |
| Domain | INTERFERON_A_B_D | 2.88e-04 | 17 | 145 | 3 | PS00252 | |
| Domain | Interferon_alpha/beta/delta | 2.88e-04 | 17 | 145 | 3 | IPR000471 | |
| Domain | IFabd | 2.88e-04 | 17 | 145 | 3 | SM00076 | |
| Domain | - | 3.43e-04 | 18 | 145 | 3 | 3.30.70.1230 | |
| Domain | Nucleotide_cyclase | 3.43e-04 | 18 | 145 | 3 | IPR029787 | |
| Domain | TEA_1 | 3.56e-04 | 4 | 145 | 2 | PS00554 | |
| Domain | TEA_2 | 3.56e-04 | 4 | 145 | 2 | PS51088 | |
| Domain | SHR-BD | 3.56e-04 | 4 | 145 | 2 | IPR009543 | |
| Domain | TEA | 3.56e-04 | 4 | 145 | 2 | PF01285 | |
| Domain | TEA/ATTS_dom | 3.56e-04 | 4 | 145 | 2 | IPR000818 | |
| Domain | TEF_metazoa | 3.56e-04 | 4 | 145 | 2 | IPR016361 | |
| Domain | PTCB-BRCT | 3.56e-04 | 4 | 145 | 2 | PF12738 | |
| Domain | TEA | 3.56e-04 | 4 | 145 | 2 | SM00426 | |
| Domain | VPS13_C | 3.56e-04 | 4 | 145 | 2 | PF16909 | |
| Domain | VPS13_C | 3.56e-04 | 4 | 145 | 2 | IPR031645 | |
| Domain | SHR-BD | 3.56e-04 | 4 | 145 | 2 | PF06650 | |
| Domain | Guanylate_cyc | 4.05e-04 | 19 | 145 | 3 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 4.05e-04 | 19 | 145 | 3 | PS50125 | |
| Domain | A/G_cyclase | 4.05e-04 | 19 | 145 | 3 | IPR001054 | |
| Domain | GUANYLATE_CYCLASE_1 | 4.05e-04 | 19 | 145 | 3 | PS00452 | |
| Domain | CYCc | 4.05e-04 | 19 | 145 | 3 | SM00044 | |
| Domain | TF_AP2 | 5.89e-04 | 5 | 145 | 2 | IPR004979 | |
| Domain | TF_AP2_C | 5.89e-04 | 5 | 145 | 2 | IPR013854 | |
| Domain | BRO1 | 5.89e-04 | 5 | 145 | 2 | PF03097 | |
| Domain | BRO1_dom | 5.89e-04 | 5 | 145 | 2 | IPR004328 | |
| Domain | BRO1 | 5.89e-04 | 5 | 145 | 2 | SM01041 | |
| Domain | TF_AP-2 | 5.89e-04 | 5 | 145 | 2 | PF03299 | |
| Domain | BRO1 | 5.89e-04 | 5 | 145 | 2 | PS51180 | |
| Domain | - | 5.89e-04 | 5 | 145 | 2 | 1.25.40.280 | |
| Domain | Growth_fac_rcpt_ | 1.38e-03 | 156 | 145 | 6 | IPR009030 | |
| Domain | DH_1 | 1.46e-03 | 63 | 145 | 4 | PS00741 | |
| Domain | Chorein_N | 1.63e-03 | 8 | 145 | 2 | PF12624 | |
| Domain | Helicase/UvrB_N | 1.63e-03 | 8 | 145 | 2 | IPR006935 | |
| Domain | PH-BEACH_dom | 1.63e-03 | 8 | 145 | 2 | IPR023362 | |
| Domain | Calx_beta | 1.63e-03 | 8 | 145 | 2 | SM00237 | |
| Domain | VPS13_N | 1.63e-03 | 8 | 145 | 2 | IPR026854 | |
| Domain | - | 1.63e-03 | 8 | 145 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 1.63e-03 | 8 | 145 | 2 | PS51783 | |
| Domain | ResIII | 1.63e-03 | 8 | 145 | 2 | PF04851 | |
| Domain | RhoGEF | 1.93e-03 | 68 | 145 | 4 | SM00325 | |
| Domain | Calx_beta | 2.08e-03 | 9 | 145 | 2 | IPR003644 | |
| Domain | BEACH | 2.08e-03 | 9 | 145 | 2 | PS50197 | |
| Domain | Beach | 2.08e-03 | 9 | 145 | 2 | PF02138 | |
| Domain | - | 2.08e-03 | 9 | 145 | 2 | 1.10.1540.10 | |
| Domain | Beach | 2.08e-03 | 9 | 145 | 2 | SM01026 | |
| Domain | BEACH_dom | 2.08e-03 | 9 | 145 | 2 | IPR000409 | |
| Domain | Calx-beta | 2.08e-03 | 9 | 145 | 2 | PF03160 | |
| Domain | RhoGEF | 2.15e-03 | 70 | 145 | 4 | PF00621 | |
| Domain | DH_2 | 2.15e-03 | 70 | 145 | 4 | PS50010 | |
| Domain | - | 2.26e-03 | 71 | 145 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 2.26e-03 | 71 | 145 | 4 | IPR000219 | |
| Domain | PTPc | 2.71e-03 | 36 | 145 | 3 | SM00194 | |
| Domain | ANF_lig-bd_rcpt | 2.94e-03 | 37 | 145 | 3 | IPR001828 | |
| Domain | ANF_receptor | 2.94e-03 | 37 | 145 | 3 | PF01094 | |
| Domain | TPR | 3.35e-03 | 129 | 145 | 5 | SM00028 | |
| Domain | Peripla_BP_I | 3.41e-03 | 39 | 145 | 3 | IPR028082 | |
| Domain | TYR_PHOSPHATASE_PTP | 3.41e-03 | 39 | 145 | 3 | PS50055 | |
| Domain | TPR_repeat | 3.82e-03 | 133 | 145 | 5 | IPR019734 | |
| Domain | PTPase_domain | 3.94e-03 | 41 | 145 | 3 | IPR000242 | |
| Domain | Y_phosphatase | 3.94e-03 | 41 | 145 | 3 | PF00102 | |
| Domain | - | 4.53e-03 | 333 | 145 | 8 | 2.130.10.10 | |
| Domain | Ig_V-set | 4.64e-03 | 199 | 145 | 6 | IPR013106 | |
| Domain | WD40/YVTN_repeat-like_dom | 4.70e-03 | 335 | 145 | 8 | IPR015943 | |
| Domain | - | 5.61e-03 | 207 | 145 | 6 | 1.25.40.10 | |
| Domain | Clathrin/coatomer_adapt-like_N | 5.88e-03 | 15 | 145 | 2 | IPR002553 | |
| Domain | Adaptin_N | 5.88e-03 | 15 | 145 | 2 | PF01602 | |
| Domain | WD_REPEATS_1 | 6.07e-03 | 278 | 145 | 7 | PS00678 | |
| Domain | HEAT | 6.14e-03 | 48 | 145 | 3 | PF02985 | |
| Domain | WD_REPEATS_2 | 6.19e-03 | 279 | 145 | 7 | PS50082 | |
| Domain | WD_REPEATS_REGION | 6.19e-03 | 279 | 145 | 7 | PS50294 | |
| Domain | - | 6.88e-03 | 50 | 145 | 3 | 1.20.1250.10 | |
| Domain | 4_helix_cytokine_core | 7.27e-03 | 51 | 145 | 3 | IPR012351 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY | 6.42e-06 | 17 | 105 | 4 | M47564 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY | 1.92e-05 | 22 | 105 | 4 | M47616 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY | 2.75e-05 | 24 | 105 | 4 | M47782 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 6.86e-05 | 30 | 105 | 4 | M936 | |
| Pathway | WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY | 7.83e-05 | 31 | 105 | 4 | M39897 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 1.27e-04 | 35 | 105 | 4 | M48246 | |
| Pathway | REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_GROWTH_FACTORS_AND_THEIR_RECEPTORS | 1.71e-04 | 15 | 105 | 3 | M27766 | |
| Pathway | KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 1.84e-04 | 71 | 105 | 5 | M15913 | |
| Pathway | BIOCARTA_IL1R_PATHWAY | 2.38e-04 | 41 | 105 | 4 | MM1493 | |
| Pathway | WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS | 3.02e-04 | 18 | 105 | 3 | M39825 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY | 3.02e-04 | 18 | 105 | 3 | M47539 | |
| Pathway | BIOCARTA_IFNA_PATHWAY | 3.57e-04 | 19 | 105 | 3 | MM1571 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY | 3.57e-04 | 19 | 105 | 3 | M47450 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM | 3.57e-04 | 19 | 105 | 3 | M47677 | |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 3.61e-04 | 82 | 105 | 5 | M1002 | |
| Pathway | WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION | 4.05e-04 | 47 | 105 | 4 | M39531 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY | 4.17e-04 | 20 | 105 | 3 | M47617 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 4.84e-04 | 21 | 105 | 3 | M47909 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY | 5.58e-04 | 22 | 105 | 3 | M47897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY | 6.38e-04 | 23 | 105 | 3 | M47452 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 6.38e-04 | 23 | 105 | 3 | MM15634 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY | 7.25e-04 | 24 | 105 | 3 | M47576 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 7.25e-04 | 24 | 105 | 3 | M47908 | |
| Pathway | KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY | 7.40e-04 | 55 | 105 | 4 | M11844 | |
| Pathway | REACTOME_RUNX3_REGULATES_YAP1_MEDIATED_TRANSCRIPTION | 8.08e-04 | 6 | 105 | 2 | MM15544 | |
| Pubmed | Aicardi-Goutières syndrome-like encephalitis in mutant mice with constitutively active MDA5. | 1.47e-09 | 27 | 148 | 6 | 33165593 | |
| Pubmed | PICH Supports Embryonic Hematopoiesis by Suppressing a cGAS-STING-Mediated Interferon Response. | 5.19e-08 | 24 | 148 | 5 | 35037428 | |
| Pubmed | 6.47e-08 | 25 | 148 | 5 | 27183626 | ||
| Pubmed | The RIPK1 death domain restrains ZBP1- and TRIF-mediated cell death and inflammation. | 7.98e-08 | 26 | 148 | 5 | 38744293 | |
| Pubmed | The RNA-editing enzyme ADAR1 controls innate immune responses to RNA. | 9.76e-08 | 27 | 148 | 5 | 25456137 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CA12 SIN3B APPBP2 OBSCN NBEA TSC2 GRIN1 ECT2 CCDC39 RYR1 IGF2BP3 THBS4 EXOC3L4 VPS13A NUP188 DOP1B | 1.13e-07 | 736 | 148 | 16 | 29676528 |
| Pubmed | 2.18e-07 | 13 | 148 | 4 | 20427526 | ||
| Pubmed | 3.01e-07 | 4 | 148 | 3 | 24478444 | ||
| Pubmed | Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response. | 3.05e-07 | 14 | 148 | 4 | 20566717 | |
| Pubmed | 1.50e-06 | 6 | 148 | 3 | 32277054 | ||
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 33983932 | ||
| Pubmed | Tead proteins activate the Foxa2 enhancer in the node in cooperation with a second factor. | 2.61e-06 | 7 | 148 | 3 | 16207754 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | UNC13B TEAD2 FRAS1 LZTR1 RTTN OBSCN TSC2 CFAP43 EDC4 RYR1 SBNO2 IFRD2 AP1G2 ZER1 ZFYVE26 NUP188 HTT | 5.17e-06 | 1105 | 148 | 17 | 35748872 |
| Pubmed | ADAR1 mediated regulation of neural crest derived melanocytes and Schwann cell development. | 5.42e-06 | 59 | 148 | 5 | 31924792 | |
| Pubmed | Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. | 5.95e-06 | 28 | 148 | 4 | 17277142 | |
| Pubmed | An essential role for Cmtr2 in mammalian embryonic development. | 6.23e-06 | 9 | 148 | 3 | 39094818 | |
| Pubmed | Antiviral Protection via RdRP-Mediated Stable Activation of Innate Immunity. | 8.87e-06 | 10 | 148 | 3 | 26633895 | |
| Pubmed | High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. | 1.22e-05 | 11 | 148 | 3 | 6444699 | |
| Pubmed | Mechanism of SUMOylation-Mediated Regulation of Type I IFN Expression. | 1.22e-05 | 11 | 148 | 3 | 36681180 | |
| Pubmed | Type I interferon dependence of plasmacytoid dendritic cell activation and migration. | 1.22e-05 | 11 | 148 | 3 | 15795237 | |
| Pubmed | 1.22e-05 | 11 | 148 | 3 | 9794439 | ||
| Pubmed | 1.22e-05 | 11 | 148 | 3 | 18835032 | ||
| Pubmed | Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. | 1.22e-05 | 11 | 148 | 3 | 10448195 | |
| Pubmed | IFN-alpha can both protect against and promote the development of type 1 diabetes. | 1.22e-05 | 11 | 148 | 3 | 19120292 | |
| Pubmed | Effect of interferon-alpha on immediate early gene expression of murine cytomegalovirus. | 1.22e-05 | 11 | 148 | 3 | 8389790 | |
| Pubmed | The mouse IFN-alpha (Ifa) locus: correlation of physical and linkage maps by in situ hybridization. | 1.22e-05 | 11 | 148 | 3 | 3456887 | |
| Pubmed | 1.22e-05 | 11 | 148 | 3 | 25310498 | ||
| Pubmed | MAVS Deficiency Is Associated With a Reduced T Cell Response Upon Secondary RSV Infection in Mice. | 1.62e-05 | 12 | 148 | 3 | 33123150 | |
| Pubmed | A novel anti-viral role for STAT3 in IFN-α signalling responses. | 1.62e-05 | 12 | 148 | 3 | 27988795 | |
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 8656058 | ||
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 6188104 | ||
| Pubmed | Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice. | 1.62e-05 | 12 | 148 | 3 | 18716002 | |
| Pubmed | Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway. | 1.62e-05 | 12 | 148 | 3 | 16611902 | |
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 30967261 | ||
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 17434974 | ||
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 8245849 | ||
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 3017340 | ||
| Pubmed | Role of interferons in the regulation of cell proliferation, differentiation, and development. | 1.62e-05 | 12 | 148 | 3 | 7530016 | |
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 9794206 | ||
| Pubmed | Isolation and mapping of four new DNA markers from mouse chromosome 4. | 1.62e-05 | 12 | 148 | 3 | 1360280 | |
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 7601556 | ||
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 16565497 | ||
| Pubmed | Regulation of effector and memory T-cell functions by type I interferon. | 1.62e-05 | 12 | 148 | 3 | 21320124 | |
| Pubmed | Evolution of the interferon alpha gene family in eutherian mammals. | 1.62e-05 | 12 | 148 | 3 | 17512142 | |
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 9425112 | ||
| Pubmed | Repression of the murine interferon alpha 11 gene: identification of negatively acting sequences. | 1.62e-05 | 12 | 148 | 3 | 1886773 | |
| Pubmed | The physical separation of Lps and Ifa loci in BXH recombinant inbred mice. | 1.62e-05 | 12 | 148 | 3 | 2572648 | |
| Pubmed | Developmental control of IFN-alpha expression in murine embryos. | 1.62e-05 | 12 | 148 | 3 | 7925651 | |
| Pubmed | The role of type 1 interferons in coagulation induced by gram-negative bacteria. | 1.62e-05 | 12 | 148 | 3 | 32016282 | |
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 28874170 | ||
| Pubmed | Multiple pathways of interferon-induced gene expression in murine macrophages. | 1.62e-05 | 12 | 148 | 3 | 7684767 | |
| Pubmed | Ligation of CD180 inhibits IFN-α signaling in a Lyn-PI3K-BTK-dependent manner in B cells. | 1.62e-05 | 12 | 148 | 3 | 26277892 | |
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 6689487 | ||
| Pubmed | Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection. | 1.62e-05 | 12 | 148 | 3 | 22912583 | |
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 23747509 | ||
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 18937499 | ||
| Pubmed | Structure and expression of a new murine interferon-alpha gene: MuIFN-alpha I9. | 1.62e-05 | 12 | 148 | 3 | 3758677 | |
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 19406830 | ||
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 22685550 | ||
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 20038206 | ||
| Pubmed | Murine alpha/beta interferons inhibit benzo(a)pyrene activation and mutagenesis in mice. | 1.62e-05 | 12 | 148 | 3 | 8304945 | |
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 11846978 | ||
| Pubmed | Identification of distal silencing elements in the murine interferon-A11 gene promoter. | 1.62e-05 | 12 | 148 | 3 | 8760352 | |
| Pubmed | Behavioral effects of mouse interferons-alpha and -gamma and human interferon-alpha in mice. | 1.62e-05 | 12 | 148 | 3 | 1422836 | |
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 17277125 | ||
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 17451966 | ||
| Pubmed | 1.62e-05 | 12 | 148 | 3 | 25897172 | ||
| Pubmed | A polymorphic trinucleotide repeat sequence mapping to distal mouse chromosome 4. | 1.62e-05 | 12 | 148 | 3 | 8672140 | |
| Pubmed | AP-2α/AP-2β Transcription Factors Are Key Regulators of Epidermal Homeostasis. | 1.80e-05 | 2 | 148 | 2 | 38237728 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 26000985 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 12748188 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 23824812 | ||
| Pubmed | Mutant huntingtin regulates EGF receptor fate in non-neuronal cells lacking wild-type protein. | 1.80e-05 | 2 | 148 | 2 | 22974559 | |
| Pubmed | A viral RNA structural element alters host recognition of nonself RNA. | 1.80e-05 | 2 | 148 | 2 | 24482115 | |
| Pubmed | Vasonatrin peptide stimulates both of the natriuretic peptide receptors, NPRA and NPRB. | 1.80e-05 | 2 | 148 | 2 | 24699414 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 37658049 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 37061993 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 25927359 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 30282041 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 39009095 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 18958173 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 22949736 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 28765884 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 27521929 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 26459629 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 33454014 | ||
| Pubmed | Adenine nucleotides decrease the apparent Km of endogenous natriuretic peptide receptors for GTP. | 1.80e-05 | 2 | 148 | 2 | 17848634 | |
| Pubmed | Mass spectrometric identification of phosphorylation sites in guanylyl cyclase A and B. | 1.80e-05 | 2 | 148 | 2 | 20977274 | |
| Pubmed | Identification and validation of Ifit1 as an important innate immune bottleneck. | 1.80e-05 | 2 | 148 | 2 | 22745654 | |
| Pubmed | AP2 transcription factor induces apoptosis in retinoblastoma cells. | 1.80e-05 | 2 | 148 | 2 | 20607706 | |
| Pubmed | Differential Complex Formation via Paralogs in the Human Sin3 Protein Interaction Network. | 1.80e-05 | 2 | 148 | 2 | 32467258 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 21954231 | ||
| Pubmed | The indolocarbazole, Gö6976, inhibits guanylyl cyclase-A and -B. | 1.80e-05 | 2 | 148 | 2 | 21366551 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 29715367 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 28465487 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 30696704 | ||
| Pubmed | Chimeric natriuretic peptide ACNP stimulates both natriuretic peptide receptors, the NPRA and NPRB. | 1.80e-05 | 2 | 148 | 2 | 23186809 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 36637178 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 36446235 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 27823966 | ||
| Cytoband | 9p22 | 7.17e-05 | 25 | 148 | 3 | 9p22 | |
| GeneFamily | TEA domain transcription factors | 1.80e-04 | 4 | 100 | 2 | 1183 | |
| GeneFamily | Guanylate cyclase receptors | 6.25e-04 | 7 | 100 | 2 | 343 | |
| GeneFamily | Interferons | 7.25e-04 | 32 | 100 | 3 | 598 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.06e-03 | 9 | 100 | 2 | 1230 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 1.06e-03 | 9 | 100 | 2 | 1306 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 1.61e-03 | 11 | 100 | 2 | 1168 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 1.93e-03 | 12 | 100 | 2 | 1243 | |
| GeneFamily | Integrator complex | 3.03e-03 | 15 | 100 | 2 | 1366 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 3.81e-03 | 115 | 100 | 4 | 769 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.84e-03 | 66 | 100 | 3 | 722 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 5.94e-03 | 21 | 100 | 2 | 813 | |
| GeneFamily | Bardet-Biedl syndrome associated|BBSome | 5.94e-03 | 21 | 100 | 2 | 980 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | CPAMD8 SFRP4 PI16 CUBN IFIH1 MCTP1 HMCN1 PTPRJ GUCY1B1 PTPRR HAS2 | 5.90e-06 | 355 | 148 | 11 | M45758 |
| ToppCell | facs-MAT-Fat-3m-Myeloid-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 164 | 148 | 7 | 1250876abd7311f86730e5b9c03c3610cc2ff6d3 | |
| ToppCell | facs-MAT-Fat-3m-Myeloid|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 164 | 148 | 7 | fa0d77b648cde5e42b9394e877168c80de238bde | |
| ToppCell | facs-MAT-Fat-3m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 164 | 148 | 7 | b81498c3934e0d52bf0329dc745e02966f9d8613 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.09e-06 | 176 | 148 | 7 | 52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.23e-06 | 188 | 148 | 7 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-06 | 189 | 148 | 7 | 92319bef1f00d6048ba8f9f8b5c6dbb896686b74 | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 192 | 148 | 7 | 144503af50274eaed5cf6effa892c640eab28663 | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 192 | 148 | 7 | c96736bb3a6bb052678b1b078f7823063ca69e6d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-06 | 193 | 148 | 7 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | droplet-Kidney-nan-21m-Endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-06 | 193 | 148 | 7 | 0e39b6c8e7382e61a9891f6c7e3df2a859788219 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-06 | 194 | 148 | 7 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.12e-06 | 195 | 148 | 7 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| ToppCell | PCW_10-12-Hematologic_Myeloid|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.12e-06 | 195 | 148 | 7 | 6352cd749091cfdbf5cce3c354fa57883cc513e8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.26e-06 | 196 | 148 | 7 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.26e-06 | 196 | 148 | 7 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.86e-06 | 200 | 148 | 7 | 66f7e8ee63c828f17468e79a4b816346b33e8980 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.60e-06 | 137 | 148 | 6 | 85b3a98039c1f68addad0334aa5b2584f6045aaa | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related-Oligodendrocyte/OPC|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.15e-05 | 151 | 148 | 6 | 4533bccc996395f74b16af939ce79b6fe253c073 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.15e-05 | 151 | 148 | 6 | edb2f59789c295838d2030b80c792cbea25eaa3d | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-05 | 156 | 148 | 6 | af47a4b17342bdb3cb62d7e2d52a81168e588629 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.72e-05 | 162 | 148 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-05 | 163 | 148 | 6 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-05 | 163 | 148 | 6 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-05 | 165 | 148 | 6 | a74751e0ec857aa974bec04ccc747c004a8f6e01 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.57e-05 | 174 | 148 | 6 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.01e-05 | 179 | 148 | 6 | 716856b2c7c660bf5ce00e63efeda6ed121f2baa | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.01e-05 | 179 | 148 | 6 | 1ac79c82c52fa95bb4e170ab20fec0f648db2134 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.20e-05 | 181 | 148 | 6 | 090e89b506d945e123e647d08947e9649a65ce7c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-05 | 181 | 148 | 6 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.30e-05 | 182 | 148 | 6 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 3.41e-05 | 183 | 148 | 6 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-05 | 183 | 148 | 6 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | PBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters | 3.51e-05 | 184 | 148 | 6 | 2e0c9a2c40c892a2d435eafb31f1f838de9baf15 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|metastatic_Brain / Location, Cell class and cell subclass | 3.62e-05 | 185 | 148 | 6 | ad52970e88e8947ef256095bd4b40229b912d58a | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 3.62e-05 | 185 | 148 | 6 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-05 | 186 | 148 | 6 | d72cdbb6d79ab33a5823c42e93c2ba566244f64c | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.84e-05 | 187 | 148 | 6 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.84e-05 | 187 | 148 | 6 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.84e-05 | 187 | 148 | 6 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.96e-05 | 188 | 148 | 6 | 5bc1537e079c7435196c163bff5f639ea392a33a | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-05 | 188 | 148 | 6 | 67c04f446fa4528b13a381622e88eb1f314cc6d5 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_migrating_dendritic_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.96e-05 | 188 | 148 | 6 | 8fc15c8b78fdd1a578e34325011bc5a87a8aab31 | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-05 | 188 | 148 | 6 | 03a7f6538cfddc230c0eab10c3613929addd7e33 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.08e-05 | 189 | 148 | 6 | a75226616340045b581d08429d2e123e041dee55 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-05 | 190 | 148 | 6 | cb8798839c27f307955fcc94a1ee40bca95b8e99 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_LZ|B_lymphocytes / Location, Cell class and cell subclass | 4.20e-05 | 190 | 148 | 6 | c5c80a6b9087821a2e07250fa90bcd3505f103b6 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial-kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-05 | 190 | 148 | 6 | 5bf3d0beee69879c95265d07fba023626a7cc808 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.20e-05 | 190 | 148 | 6 | 49e09cdb843b3d889a06a811aa5affae68b25a75 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_dendritic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.32e-05 | 191 | 148 | 6 | a5ee4d72b2311c8fa98ff73adc2499debb2014f1 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.32e-05 | 191 | 148 | 6 | c383ae386bc53e73a683a9543c7dfed2a65257c5 | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-05 | 191 | 148 | 6 | dc58d45fafd224d2761aefbe0ce79f66b50c1c03 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Endothelial-kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-05 | 192 | 148 | 6 | c0498baa2556e1597c00df2e75efadeb14bd34ef | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-05 | 192 | 148 | 6 | 40f44ac4ab673ee6156abdd2074a60b9de3281ad | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.45e-05 | 192 | 148 | 6 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Endothelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-05 | 192 | 148 | 6 | cb906b10cad76e978c5c0b966215368ebef30e51 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.58e-05 | 193 | 148 | 6 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.58e-05 | 193 | 148 | 6 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-05 | 194 | 148 | 6 | be869e186386d03ebb670971dd24fa656b4b0edf | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-05 | 194 | 148 | 6 | 4d6c9b016e3a0641954a8ea10c97d1cd76fadd9f | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.72e-05 | 194 | 148 | 6 | 846b4170544cdf58b536fb7a5fd34b79b0b17993 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte1_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.72e-05 | 194 | 148 | 6 | fad22d5cf62016cad979e6943e357106d8d2a4b4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-05 | 195 | 148 | 6 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.85e-05 | 195 | 148 | 6 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | C_05|World / shred on cell type and cluster | 4.99e-05 | 196 | 148 | 6 | bf4dfb460a153dbafb2b9b12b360c8757cec22cd | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.14e-05 | 197 | 148 | 6 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.14e-05 | 197 | 148 | 6 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.14e-05 | 197 | 148 | 6 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.43e-05 | 199 | 148 | 6 | 744b63fba33b176ab7dde11646ccb313665505f7 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.58e-05 | 200 | 148 | 6 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.58e-05 | 200 | 148 | 6 | ed093626a9cac7531a2bf02f6e345c5e84b8c060 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.58e-05 | 200 | 148 | 6 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 5.58e-05 | 200 | 148 | 6 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.58e-05 | 200 | 148 | 6 | 8a4c210a3130f7baedf15ecbc0f4903b97da0352 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.58e-05 | 200 | 148 | 6 | 85c0f038bcfb42669dca2b80273b0f8a1421405e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.68e-05 | 131 | 148 | 5 | d706405453408fbcfcabb1c7702b80f9e649ffca | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 140 | 148 | 5 | e442c46979d725ec82f525a001c46d971fcade4d | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-04 | 145 | 148 | 5 | b17699f7f98d2361a4d26c26f52db05e7ff69dff | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 145 | 148 | 5 | 9964d6d3769be2f35d86268fe044cecd1d5a1616 | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-04 | 148 | 148 | 5 | 5983c4546f527a0b599cfcbd8a6cb937a1d6f895 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.41e-04 | 149 | 148 | 5 | 41f28138bde45d0b814e116837e5a32b5e80d54a | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.74e-04 | 156 | 148 | 5 | 2cd007b423c2395c5ce331902e7f27c805755eb3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 157 | 148 | 5 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 158 | 148 | 5 | 7960337d87afecf2692ab65e5991f052ceddfacc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 158 | 148 | 5 | debebc8534a80e5500051f6fd352dc201585968d | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 159 | 148 | 5 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 159 | 148 | 5 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.90e-04 | 159 | 148 | 5 | 0dccc4275b9b4f8554dd556da7218e130bff8fd1 | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 160 | 148 | 5 | 5c28121916a12dbc22ef2421040bdc9148a40b78 | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 160 | 148 | 5 | b7093678987575f2f99d648821d31b4a37075aca | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-04 | 160 | 148 | 5 | 1e210e526ea4d84fc58a798a26c0929bcb69fd89 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 2.14e-04 | 163 | 148 | 5 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-04 | 164 | 148 | 5 | d847d509bb1791638032ade6755d8164586b5bd5 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.33e-04 | 166 | 148 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.33e-04 | 166 | 148 | 5 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-04 | 166 | 148 | 5 | 6fe8db8d45177a78605681f22e04fa8d0594f2df | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.33e-04 | 166 | 148 | 5 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.39e-04 | 167 | 148 | 5 | f01b96173deda0239fa482989873cf308e49d48c | |
| ToppCell | Control-Lymphocytic_B-B_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.39e-04 | 167 | 148 | 5 | a15a70d3837b31cc83a2a9e3f1bbfd77a95f2312 | |
| ToppCell | Control-Lymphocytic_B|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.39e-04 | 167 | 148 | 5 | 956da82394fd6a9f45fc2031796f12cc889542cd | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.39e-04 | 167 | 148 | 5 | 5fc85a05124cd2324e1b8ff940193880f83cd8af | |
| Computational | Genes in the cancer module 65. | 4.94e-05 | 10 | 82 | 3 | MODULE_65 | |
| Computational | Genes in the cancer module 445. | 1.82e-04 | 15 | 82 | 3 | MODULE_445 | |
| Drug | barium iodide | 1.07e-06 | 4 | 148 | 3 | CID000083684 | |
| Drug | B132 | 2.67e-06 | 5 | 148 | 3 | CID002734031 | |
| Drug | AC1O3GBZ | 3.48e-06 | 36 | 148 | 5 | CID006327751 | |
| Drug | p203 | 4.89e-06 | 18 | 148 | 4 | CID000019228 | |
| Drug | HCV-371 | 5.31e-06 | 6 | 148 | 3 | CID003013096 | |
| Drug | Murabutida | 8.56e-06 | 43 | 148 | 5 | CID005362018 | |
| Drug | Yfrkd | 9.24e-06 | 7 | 148 | 3 | CID000129984 | |
| Drug | ridostin | 1.10e-05 | 116 | 148 | 7 | CID011979623 | |
| Drug | AC1LAD6M | 1.47e-05 | 8 | 148 | 3 | CID000511663 | |
| Drug | 1hiv | 1.47e-05 | 8 | 148 | 3 | CID005479205 | |
| Drug | Chebi:36708 | 1.47e-05 | 8 | 148 | 3 | CID011966289 | |
| Drug | O4-[3-[(1S)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] O1-[3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (Z)-2-chlorobut-2-enedioate | 1.47e-05 | 8 | 148 | 3 | CID010011375 | |
| Drug | HMPV | 1.95e-05 | 25 | 148 | 4 | CID004444603 | |
| Drug | Telaprevir | 2.20e-05 | 9 | 148 | 3 | CID003010818 | |
| Drug | boceprevir | 2.20e-05 | 9 | 148 | 3 | CID010324367 | |
| Drug | pipobroman | 3.12e-05 | 10 | 148 | 3 | CID000004842 | |
| Drug | AC1NRA8N | 3.40e-05 | 189 | 148 | 8 | CID005287758 | |
| Drug | NMMA | 3.47e-05 | 94 | 148 | 6 | CID000170607 | |
| Drug | Nocodazole [31430-18-9]; Down 200; 13.2uM; PC3; HT_HG-U133A | 3.53e-05 | 190 | 148 | 8 | 7145_DN | |
| Drug | S-nitrosoacetylcysteine | 3.59e-05 | 29 | 148 | 4 | CID000122058 | |
| Drug | Erythrityl Tetranitrate | 4.20e-05 | 2 | 148 | 2 | DB01613 | |
| Drug | flesinoxan | 4.27e-05 | 11 | 148 | 3 | CID000057347 | |
| Drug | SC-57099B | 4.27e-05 | 11 | 148 | 3 | CID000178079 | |
| Drug | Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A | 4.40e-05 | 196 | 148 | 8 | 2681_UP | |
| Drug | strontium chromate | 4.64e-05 | 99 | 148 | 6 | CID000024599 | |
| Drug | L(-)-vesamicol hydrochloride [112709-59-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 4.73e-05 | 198 | 148 | 8 | 6497_DN | |
| Drug | Amiloride hydrochloride dihydrate [17440-83-4]; Up 200; 13.2uM; HL60; HG-U133A | 4.90e-05 | 199 | 148 | 8 | 1970_UP | |
| Drug | imidazoquinoline | 5.20e-05 | 101 | 148 | 6 | CID005351568 | |
| Drug | casopitant | 5.67e-05 | 12 | 148 | 3 | CID009917021 | |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | CA12 KNTC1 TEAD2 BRINP3 TOPBP1 RELA MSH4 ECT2 NCAPG2 RYR1 USP31 IFIH1 TBC1D32 NWD2 MCTP1 KCNQ5 PTPRJ SCN2A LTN1 DMD ARHGEF37 HAS2 TBC1D21 | 5.70e-05 | 1441 | 148 | 23 | ctd:C009828 |
| Drug | Excitatory Amino Acid Agonists | 6.06e-05 | 33 | 148 | 4 | ctd:D018690 | |
| Drug | R 842 | 7.34e-05 | 13 | 148 | 3 | CID000130714 | |
| Drug | AC1O52EF | 7.34e-05 | 13 | 148 | 3 | CID006450817 | |
| Drug | 2-fluoroadenine arabinoside | 8.00e-05 | 158 | 148 | 7 | CID000003367 | |
| Drug | Lanicemine | 9.30e-05 | 14 | 148 | 3 | CID003038485 | |
| Drug | gunacin | 9.30e-05 | 14 | 148 | 3 | CID000198547 | |
| Disease | Polydactyly | 2.17e-05 | 117 | 141 | 6 | C0152427 | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 6.78e-05 | 3 | 141 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | body weight | UNC13B KNTC1 BRINP3 COPB1 RTTN VIRMA TFAP2B SBNO2 GHSR NBAS IGF2BP3 KCNQ5 PTPRJ PTPRR CAPZA3 DMD TBC1D21 | 1.14e-04 | 1261 | 141 | 17 | EFO_0004338 |
| Disease | Clinodactyly | 1.35e-04 | 4 | 141 | 2 | C4551485 | |
| Disease | Clinodactyly of fingers | 1.35e-04 | 4 | 141 | 2 | C0265610 | |
| Disease | Colorectal Carcinoma | UNC13B CPAMD8 SFRP4 OBSCN ARFGEF1 CUBN LIG1 KCNQ5 EGFR INTS13 VPS13A DMD | 1.46e-04 | 702 | 141 | 12 | C0009402 |
| Disease | Ciliopathies | 1.90e-04 | 110 | 141 | 5 | C4277690 | |
| Disease | thrombocytopenia (implicated_via_orthology) | 4.69e-04 | 7 | 141 | 2 | DOID:1588 (implicated_via_orthology) | |
| Disease | Epilepsy, Cryptogenic | 6.55e-04 | 82 | 141 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 6.55e-04 | 82 | 141 | 4 | C0751111 | |
| Disease | Aura | 6.55e-04 | 82 | 141 | 4 | C0236018 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 7.42e-04 | 148 | 141 | 5 | C0279702 | |
| Disease | dilated cardiomyopathy (is_marker_for) | 8.61e-04 | 39 | 141 | 3 | DOID:12930 (is_marker_for) | |
| Disease | Congenital small ears | 9.97e-04 | 41 | 141 | 3 | C0152423 | |
| Disease | sleep disorder (implicated_via_orthology) | 1.21e-03 | 11 | 141 | 2 | DOID:535 (implicated_via_orthology) | |
| Disease | quality of life during menstruation measurement, acne | 1.21e-03 | 11 | 141 | 2 | EFO_0003894, EFO_0009366 | |
| Disease | Intellectual Disability | 1.43e-03 | 447 | 141 | 8 | C3714756 | |
| Disease | Alzheimer disease, dementia | 1.45e-03 | 12 | 141 | 2 | MONDO_0001627, MONDO_0004975 | |
| Disease | Abnormality of refraction | GALNT14 EVC NBEA PCDHA3 TFAP2B THBS4 KCNQ5 PTPRR SCN2A DYNLL1 | 1.52e-03 | 673 | 141 | 10 | HP_0000539 |
| Disease | congenital left-sided heart lesions | 1.58e-03 | 48 | 141 | 3 | EFO_0005938 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.68e-03 | 49 | 141 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Epilepsy | 1.89e-03 | 109 | 141 | 4 | C0014544 | |
| Disease | trimethylamine-N-oxide measurement | 1.99e-03 | 14 | 141 | 2 | EFO_0010541 | |
| Disease | Huntington's disease (is_marker_for) | 2.10e-03 | 53 | 141 | 3 | DOID:12858 (is_marker_for) | |
| Disease | glycerate measurement | 2.29e-03 | 15 | 141 | 2 | EFO_0021029 | |
| Disease | gliosarcoma | 2.60e-03 | 16 | 141 | 2 | C0206726 | |
| Disease | ankle brachial index | 2.60e-03 | 16 | 141 | 2 | EFO_0003912 | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 2.94e-03 | 17 | 141 | 2 | C2936862 | |
| Disease | Brain Ischemia | 3.00e-03 | 60 | 141 | 3 | C0007786 | |
| Disease | Cerebral Ischemia | 3.00e-03 | 60 | 141 | 3 | C0917798 | |
| Disease | Squamous cell carcinoma | 3.01e-03 | 124 | 141 | 4 | C0007137 | |
| Disease | progression free survival, ovarian carcinoma | 3.30e-03 | 18 | 141 | 2 | EFO_0001075, EFO_0004920 | |
| Disease | Bardet-Biedl syndrome | 3.30e-03 | 18 | 141 | 2 | cv:C0752166 | |
| Disease | hypertension (implicated_via_orthology) | 3.37e-03 | 128 | 141 | 4 | DOID:10763 (implicated_via_orthology) | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 3.68e-03 | 19 | 141 | 2 | DOID:2876 (is_marker_for) | |
| Disease | myocardial infarction (implicated_via_orthology) | 3.92e-03 | 66 | 141 | 3 | DOID:5844 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QGVEETNIELLVCNY | 151 | Q6UXB8 | |
| QESVDQLSLILSYEC | 926 | Q8NAT2 | |
| VNLQVEDSGLYQCVI | 101 | Q9NP99 | |
| QNEAEYLRVVLLCAL | 111 | Q96KX2 | |
| DQAIQCVAEILGETY | 626 | Q17RC7 | |
| LQERFVQAALSYIAC | 251 | Q76B58 | |
| NYALSCNLREELVAV | 1586 | Q8NDM7 | |
| KCDAYLQQTQELVIL | 121 | O60583 | |
| VLLLACNISETIQAY | 51 | O75871 | |
| CAEKTDYVNLIQELA | 161 | Q49AH0 | |
| AVECLYNNIVIETLL | 511 | Q96NH3 | |
| AIAQEIYVDLIEDSC | 16 | Q96GX2 | |
| SITGYVDRDIQLLCQ | 141 | Q6UX41 | |
| LCVTELKNNVAAYLD | 281 | A1IGU5 | |
| IACIFSIQLERDAYV | 986 | Q9Y6D6 | |
| IYGSCLDVELQQRAV | 551 | O75843 | |
| LNCLLVAVRANNYEI | 381 | Q8WXK1 | |
| VCAAVTALQNYLTEA | 391 | P05549 | |
| ECQVAVLLDLARSYQ | 2501 | Q8IYW2 | |
| VYADTIKDLLANCAI | 186 | Q8WXI4 | |
| IILTCIAEDQYANAF | 396 | Q5T2E6 | |
| VDNICQSVAIYQAAL | 301 | Q92624 | |
| QVVTLLNDLYTCFDA | 881 | P20594 | |
| DILQIINCLTTIYDR | 3146 | P11532 | |
| QVVTLLNDLYTCFDA | 896 | P16066 | |
| AVQVAYITQVNEDCV | 451 | Q6ZW61 | |
| CAALTALQNYLTEAL | 411 | Q92481 | |
| EIYALENTLQVLNSC | 691 | Q9UFE4 | |
| YDNVNSCLLSEVEIK | 1036 | Q9ULI1 | |
| LLINSDIVCEQDIYE | 136 | P25791 | |
| TAADLNLVLYVCETV | 1286 | Q6P2E9 | |
| VANTICKADAENLIY | 791 | Q9H8V3 | |
| ACQVEVRLLLAYNSS | 906 | Q96HW7 | |
| EQTLVQSNICLYIDK | 646 | P20702 | |
| VLCALTEANVQYAAV | 626 | Q9H3S7 | |
| LTEEDVLNCQKTIYN | 486 | Q9NVM9 | |
| LTDNIQCEIFQVLYE | 116 | Q9Y3D8 | |
| EDLVCKLADISINYV | 591 | O94822 | |
| ILTNQDQQICAYLEE | 1221 | Q8N1W1 | |
| ILYDIAQCENKDVIA | 806 | Q7Z5J8 | |
| ELYQQLNDLEACVIQ | 111 | P01566 | |
| DQYVFLNQCVLDIVR | 1286 | Q12913 | |
| AALVDVNVYLIVAIC | 691 | Q9Y5H8 | |
| VIEQYCTLTILDDTQ | 2861 | Q86XX4 | |
| IYAIQEVCVSVQNIL | 881 | Q6DN14 | |
| CRQYIEASVDLQNVL | 566 | Q8N653 | |
| NVCYVVLAVFLSEQD | 41 | Q6ZVK8 | |
| SDICQYIAIVIATNE | 846 | P59045 | |
| DCYLQNVAISTLLEV | 806 | Q9Y3R5 | |
| IESKLDCLLDIYQQV | 616 | Q9NR82 | |
| VLLVAAYEAERQLCL | 56 | Q8IYD8 | |
| SQEQLLALETALYCT | 246 | O43570 | |
| SVECATQALEKYNIE | 21 | P63167 | |
| LYAACILQVELVARA | 141 | Q9P2G9 | |
| EISQANVICIVYAVN | 71 | Q8IXI2 | |
| ACIDIYFVQVVIVAN | 191 | Q8NGC6 | |
| NSSIIACYNELIQIE | 241 | O95263 | |
| AAQCYIDLIIKESDN | 281 | P53618 | |
| IICEATQIIDYLEQT | 86 | Q8TB36 | |
| VIAEVYSQICQVSEE | 391 | Q8N819 | |
| ELYQQLNDLEACVIQ | 111 | P01567 | |
| ISLKDYQNTEEVCQL | 671 | P50748 | |
| DLVVTQCGNAIYRVL | 226 | Q02153 | |
| LYEEEICLLQSQISE | 256 | Q9NSB4 | |
| QVVTAVEYQEAILAC | 36 | P57087 | |
| LCDNLVTLETLVYEA | 881 | A2RRP1 | |
| VLDSLLVQYGVVESC | 96 | O00425 | |
| IKVNNTLTLECEAYA | 2686 | Q96RW7 | |
| EVLVISVNECDNYTI | 516 | Q15256 | |
| YTQQILQEELCLSVI | 466 | Q96FL9 | |
| NCALLEQAYAVVSAL | 5856 | Q5VST9 | |
| ICTLSQLEAILLDYQ | 291 | Q8TEZ7 | |
| TIALCYGEQALIIDQ | 236 | O75344 | |
| LINYEAISAATACLQ | 1036 | O60494 | |
| NNCEVVLGNLEITYV | 56 | P00533 | |
| EDLACQKISYNVTDL | 46 | P20848 | |
| INQSKAIDYEACDLV | 876 | Q9BYE9 | |
| VQLRVNYCLLDSDQV | 1456 | P42858 | |
| VEELLCNLNSILYDT | 1596 | Q8NF50 | |
| EIAQISQYCNLVSFV | 296 | Q92847 | |
| AIELCAATLQEYVEQ | 641 | O75460 | |
| EIAEAQQLITICREY | 1046 | P53621 | |
| LDVLVDYLSFAQCSV | 136 | Q8IVF7 | |
| CDLETNSEINKLIIY | 36 | Q5K131 | |
| TQDTCVALQALAEYA | 1416 | Q8IZJ3 | |
| LAEAQTYLDKVENTC | 111 | Q5T764 | |
| LNKTVALCIAAYQED | 81 | Q92819 | |
| CNIVIRYGLVTNEIA | 801 | Q9BYX4 | |
| YCEATLLQQLVRSIA | 276 | Q8IV38 | |
| CEAISKLQENYIAAE | 461 | Q8IY85 | |
| YVAAADIQDLVSCLA | 256 | Q12894 | |
| VPVANDCYIVLLDQD | 581 | Q9Y2E5 | |
| LAEAQTYLDKVENIC | 111 | P09914 | |
| RATEAVVALCQELYF | 511 | P57679 | |
| QIFSVSEDCLVLNVY | 116 | Q6UWW8 | |
| VDASEIQVQVCLYAF | 646 | P18858 | |
| VLNCIDRLNVYTTAA | 486 | P21817 | |
| VVLCISVDVSQDYNQ | 86 | Q06136 | |
| ACSETYVVNLLLVSN | 186 | Q8NGL9 | |
| QKTCQVLIIDDSLYE | 1961 | P0C091 | |
| KSLEQLSDVILQCYE | 1836 | Q86VV8 | |
| YSVCAEILDQIVDLS | 426 | Q9C093 | |
| YLLNIAEVQAVSRCD | 226 | Q13049 | |
| EKILLLSYVCNTQAE | 146 | Q8IYX1 | |
| ALSELAALCYVIAFQ | 311 | P0DJD1 | |
| VIEELSCVRSNNYVQ | 51 | Q7Z6M4 | |
| NTLYEILTEQVCTQV | 811 | Q8NFP9 | |
| QTLDAETDVLCAVLY | 56 | Q6NW34 | |
| LSQTYLECVQAQAVI | 151 | Q8TE76 | |
| IVSDEICVQVTDLYL | 1011 | Q96ST3 | |
| VSDDVCLKVVELYLN | 901 | O75182 | |
| ALSALQLEAITYACQ | 246 | Q9Y2G9 | |
| QLEAITYACQQHEVL | 251 | Q9Y2G9 | |
| LEYIEQLCIAEFSTV | 251 | O15457 | |
| DTQELLLCTAYVFEV | 416 | Q15562 | |
| ELYQQLNDLEACVIQ | 111 | P05014 | |
| LSAICEYQLEEIQRV | 326 | Q9C0C4 | |
| ESRLIEAYVIQCQAE | 176 | Q5VW32 | |
| EAYVIQCQAEAQEVT | 181 | Q5VW32 | |
| CDTDIQNKLYADIVL | 286 | Q8TDG2 | |
| NESENYEALLECVII | 111 | Q86XI2 | |
| ENCLQALADVEVKYI | 86 | Q9BYT8 | |
| LELYLDCIQVDSVHN | 141 | P35443 | |
| NAIVNCAELVTYDLI | 186 | P55851 | |
| ICDRLVNEYVELVNA | 46 | Q7Z7L7 | |
| YICASVEFLQTVANV | 1506 | Q96RL7 | |
| QFTDLDLQCEIISYI | 96 | Q86YE8 | |
| DAVALQYCVVNILSV | 51 | Q969K7 | |
| TCQRYLQAAISLDIA | 81 | Q7Z6I5 | |
| CIQYEVLEAAQLAIE | 546 | Q96IC2 | |
| LAIEQYEELVDVNCS | 56 | Q6FHJ7 | |
| DQDSQYVCFTLVLQV | 56 | Q96BH1 | |
| DVSVVNNYSECKALI | 1376 | Q99250 | |
| IQYLQATDCVRLSLQ | 256 | Q6ZS81 | |
| QVFVDQCYQLLRTAT | 316 | Q8IZM8 | |
| YQKVCEDLDTSVNLA | 206 | P45880 | |
| QYSQLVLNVCETLQE | 1226 | Q5SRE5 | |
| QCAVLDLALDTIKQY | 1351 | O14795 | |
| LSVTEAQDKILYCLQ | 736 | Q92543 | |
| NRDTQETLLCIAYVF | 401 | Q15561 | |
| EQAVAAIVCTFQEYA | 6 | P33764 | |
| QLSEDEVCTQTAYIL | 746 | Q70CQ4 | |
| DYDLNAVRLCFQVTV | 151 | Q04206 | |
| VNIAEAAAQNVYCLR | 1451 | Q92547 | |
| EYVTSILQSLCDQDI | 1281 | Q69YN4 | |
| LEILAYCISDTAVQE | 1491 | Q68DK2 | |
| EVSLQVLDAVVCYNC | 216 | P49815 | |
| QDYINLVQCETLEDL | 31 | Q8N8Y2 | |
| FIAVENIDSYCVLIS | 4266 | Q5THJ4 | |
| LSVCEDLISSQVYAI | 76 | Q05586 |